Goldman Sachs’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$86.2M Sell
685,865
-51,572
-7% -$6.48M 0.01% 838
2025
Q1
$81.6M Sell
737,437
-246,362
-25% -$27.2M 0.01% 776
2024
Q4
$134M Sell
983,799
-33,355
-3% -$4.55M 0.02% 551
2024
Q3
$117M Sell
1,017,154
-115,435
-10% -$13.3M 0.02% 619
2024
Q2
$156M Buy
1,132,589
+356,862
+46% +$49.1M 0.03% 521
2024
Q1
$107M Buy
775,727
+84,095
+12% +$11.6M 0.02% 638
2023
Q4
$91.1M Sell
691,632
-95,323
-12% -$12.6M 0.02% 705
2023
Q3
$88.5M Sell
786,955
-37,682
-5% -$4.24M 0.02% 669
2023
Q2
$77.8M Sell
824,637
-145,163
-15% -$13.7M 0.02% 719
2023
Q1
$98.2M Sell
969,800
-359,922
-27% -$36.4M 0.02% 614
2022
Q4
$159M Buy
1,329,722
+127,932
+11% +$15.3M 0.04% 434
2022
Q3
$128M Sell
1,201,790
-53,033
-4% -$5.63M 0.03% 500
2022
Q2
$122M Sell
1,254,823
-241,629
-16% -$23.6M 0.03% 521
2022
Q1
$140M Sell
1,496,452
-28,063
-2% -$2.63M 0.03% 501
2021
Q4
$130M Buy
1,524,515
+81,017
+6% +$6.9M 0.03% 558
2021
Q3
$138M Buy
1,443,498
+20,210
+1% +$1.94M 0.03% 496
2021
Q2
$139M Buy
1,423,288
+15,814
+1% +$1.54M 0.03% 480
2021
Q1
$137M Buy
1,407,474
+189,709
+16% +$18.4M 0.03% 445
2020
Q4
$117M Buy
1,217,765
+328,594
+37% +$31.5M 0.03% 464
2020
Q3
$85.5M Sell
889,171
-55,498
-6% -$5.34M 0.02% 571
2020
Q2
$115M Buy
944,669
+42,587
+5% +$5.2M 0.04% 453
2020
Q1
$78.1M Buy
902,082
+242,342
+37% +$21M 0.03% 560
2019
Q4
$70.9M Sell
659,740
-8,347
-1% -$897K 0.02% 820
2019
Q3
$60.2M Buy
668,087
+95,698
+17% +$8.62M 0.02% 883
2019
Q2
$48.3M Buy
572,389
+37,857
+7% +$3.2M 0.01% 1040
2019
Q1
$47.1M Sell
534,532
-43,115
-7% -$3.8M 0.01% 1052
2018
Q4
$41.3M Sell
577,647
-733,011
-56% -$52.3M 0.01% 1076
2018
Q3
$161M Sell
1,310,658
-128,782
-9% -$15.8M 0.04% 453
2018
Q2
$141M Sell
1,439,440
-341,934
-19% -$33.6M 0.04% 507
2018
Q1
$148M Sell
1,781,374
-351,821
-16% -$29.2M 0.04% 524
2017
Q4
$166M Sell
2,133,195
-305,162
-13% -$23.7M 0.04% 475
2017
Q3
$149M Sell
2,438,357
-235,860
-9% -$14.5M 0.04% 493
2017
Q2
$123M Buy
2,674,217
+930,268
+53% +$42.8M 0.03% 561
2017
Q1
$75.5M Buy
1,743,949
+997,434
+134% +$43.2M 0.02% 796
2016
Q4
$28.9M Buy
746,515
+24,619
+3% +$953K 0.01% 1298
2016
Q3
$36.6M Buy
721,896
+81,257
+13% +$4.11M 0.01% 1146
2016
Q2
$29.1M Sell
640,639
-142,600
-18% -$6.48M 0.01% 1195
2016
Q1
$31M Buy
783,239
+574,102
+275% +$22.7M 0.01% 1148
2015
Q4
$11.8M Sell
209,137
-112,837
-35% -$6.38M ﹤0.01% 1597
2015
Q3
$12.8M Buy
321,974
+87,128
+37% +$3.47M ﹤0.01% 1517
2015
Q2
$11.2M Sell
234,846
-333,762
-59% -$15.9M ﹤0.01% 1635
2015
Q1
$22.6M Buy
568,608
+154,995
+37% +$6.15M 0.01% 1252
2014
Q4
$9.24M Sell
413,613
-203,819
-33% -$4.55M ﹤0.01% 1649
2014
Q3
$9.68M Sell
617,432
-4,647
-0.7% -$72.8K ﹤0.01% 1624
2014
Q2
$9.23M Sell
622,079
-119,491
-16% -$1.77M ﹤0.01% 1654
2014
Q1
$11.9M Buy
741,570
+321,720
+77% +$5.18M ﹤0.01% 1500
2013
Q4
$3.92M Sell
419,850
-120,142
-22% -$1.12M ﹤0.01% 2170
2013
Q3
$6.11M Buy
539,992
+187,314
+53% +$2.12M ﹤0.01% 1771
2013
Q2
$4.72M Buy
+352,678
New +$4.72M ﹤0.01% 1808